Lista de obras - Itziar Oyagüez - Dominio Público Uruguay

Budget impact analysis of dexamethasone intravitreal implant for the treatment of diabetic macular oedema

artículo científico publicado en 2018

Budget impact of a set-dose combination of efavirenz-emtricitabine-tenofovir in the treatment of patients infected with HIV-1

artículo científico publicado en 2009

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain

artículo científico publicado en 2012

Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.

artículo científico publicado en 2015

Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999-2000.

artículo científico publicado en 2004

Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain

artículo científico publicado en 2015

Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs

artículo científico publicado en 2012

Cost analysis of biologic drugs in rheumatoid arthritis first line treatment after methotrexate failure according to patients' body weight.

artículo científico publicado en 2015

Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on-demand therapy with activated factor VII in severe haemophilia A patients with inhibitors, in Spain.

artículo científico publicado en 2015

Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus

artículo científico publicado en 2020

Cost analysis of the use of botulinum toxin type A in Spain

artículo científico publicado en 2014

Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis.

artículo científico publicado en 2015

Cost effectiveness of prostacyclins in pulmonary arterial hypertension

artículo científico

Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention

scientific article published on 31 October 2019

Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain.

artículo científico publicado en 2016

Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis B.

artículo científico publicado en 2017

Cost-Effectiveness of Fixed-Dose Combinations Therapies for Chronic Obstructive Pulmonary Disease Treatment.

artículo científico publicado en 2018

Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain

artículo científico publicado en 2016

Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients

scientific article published on 17 September 2020

Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer in progression following anthracycline chemotherapy, in Spain ⬇️

artículo científico publicado el 1 de octubre de 2010

Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses

artículo científico publicado en 2012

Cost-effectiveness analysis of apixaban compared to low-molecularweight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism

artículo científico publicado en 2016

Cost-effectiveness analysis of celecoxib versus non-selective non-steroidal anti-inflammatory drug therapy for the treatment of osteoarthritis in Spain: A current perspective

artículo científico publicado en 2015

Cost-effectiveness analysis of ledipasvir/sofosbuvir in patients with chronic hepatitis C: Treatment of patients with absence or mild fibrosis compared to patients with advanced fibrosis.

artículo científico publicado en 2017

Cost-effectiveness analysis of sofosbuvir, peginterferon and ribavirin in patients with chronic hepatitis C: Early treatment in the initial stage of fibrosis vs. delayed treatment in advanced fibrosis

artículo científico publicado en 2016

Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain

artículo científico publicado en 2020

Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasms.

artículo científico publicado en 2017

Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system

artículo científico publicado en 2010

Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain

artículo científico publicado en 2014

Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain.

artículo científico publicado en 2017

Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients

artículo científico publicado en 2014

Efficiency of naproxen/esomeprazole in association for osteoarthrosis treatment in Spain.

artículo científico publicado en 2013

Efficiency of oncologic treatments for solid tumours in Spain

artículo científico publicado en 2013

Epidemiology of invasive streptococcus pneumoniae infections in children in Spain, 1996-1998.

artículo científico publicado en 2002

Epidemiology of primary varicella hospitalizations in Spain.

artículo científico publicado en 2001

Erectile dysfunction in a primary care setting: results of an observational, no-control-group, prospective study with sildenafil under routine conditions of use.

artículo científico publicado en 2001

Evaluation of the costs of transient elastography (FibroScan(®)) in the diagnosis of liver fibrosis in HIV patients with hepatitis C virus

artículo científico publicado en 2011

Hospital admissions for pertussis in Spain, 1995-1998.

artículo científico publicado en 2001

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.

artículo científico publicado en 2015

Status of oral anticoagulant treatment in patients with nonvalvular atrial fibrillation in Spain. REACT-AF Study

artículo científico publicado en 2014

Surgical Treatment of Pressure Ulcers with a Fibrin Sealant in Patients with Spinal Cord Injury: A Cost-Consequence Analysis.

artículo científico publicado en 2015

Systematic review of the evidence on the epidemiology of herpes zoster: incidence in the general population and specific subpopulations in Spain

artículo científico publicado en 2019

The burden of severe varicella in Spain, 1995--2000 period.

artículo científico publicado en 2004

The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain

scientific article published on 06 August 2007

[Cost-effectiveness analysis of aflibercept in combination with FOLFIRI in the treatment of patients with metastatic colorectal cancer].

artículo científico publicado en 2014

Lista de obras de Itziar Oyagüez

Budget impact analysis of dexamethasone intravitreal implant for the treatment of diabetic macular oedema

Budget impact of a set-dose combination of efavirenz-emtricitabine-tenofovir in the treatment of patients infected with HIV-1

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain

Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.

Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999-2000.

Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain

Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs

Cost analysis of biologic drugs in rheumatoid arthritis first line treatment after methotrexate failure according to patients' body weight.

Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on-demand therapy with activated factor VII in severe haemophilia A patients with inhibitors, in Spain.

Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus

Cost analysis of the use of botulinum toxin type A in Spain

Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis.

Cost effectiveness of prostacyclins in pulmonary arterial hypertension

Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention

Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain.

Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis B.

Cost-Effectiveness of Fixed-Dose Combinations Therapies for Chronic Obstructive Pulmonary Disease Treatment.

Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain

Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients

Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer in progression following anthracycline chemotherapy, in Spain ⬇️

Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses

Cost-effectiveness analysis of apixaban compared to low-molecularweight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism

Cost-effectiveness analysis of celecoxib versus non-selective non-steroidal anti-inflammatory drug therapy for the treatment of osteoarthritis in Spain: A current perspective

Cost-effectiveness analysis of ledipasvir/sofosbuvir in patients with chronic hepatitis C: Treatment of patients with absence or mild fibrosis compared to patients with advanced fibrosis.

Cost-effectiveness analysis of sofosbuvir, peginterferon and ribavirin in patients with chronic hepatitis C: Early treatment in the initial stage of fibrosis vs. delayed treatment in advanced fibrosis

Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain

Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasms.

Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system

Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain

Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain.

Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients

Efficiency of naproxen/esomeprazole in association for osteoarthrosis treatment in Spain.

Efficiency of oncologic treatments for solid tumours in Spain

Epidemiology of invasive streptococcus pneumoniae infections in children in Spain, 1996-1998.

Epidemiology of primary varicella hospitalizations in Spain.

Erectile dysfunction in a primary care setting: results of an observational, no-control-group, prospective study with sildenafil under routine conditions of use.

Evaluation of the costs of transient elastography (FibroScan(®)) in the diagnosis of liver fibrosis in HIV patients with hepatitis C virus

Hospital admissions for pertussis in Spain, 1995-1998.

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.

Status of oral anticoagulant treatment in patients with nonvalvular atrial fibrillation in Spain. REACT-AF Study

Surgical Treatment of Pressure Ulcers with a Fibrin Sealant in Patients with Spinal Cord Injury: A Cost-Consequence Analysis.

Systematic review of the evidence on the epidemiology of herpes zoster: incidence in the general population and specific subpopulations in Spain

The burden of severe varicella in Spain, 1995--2000 period.

The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain

[Cost-effectiveness analysis of aflibercept in combination with FOLFIRI in the treatment of patients with metastatic colorectal cancer].